The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Sanofi
SNY
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$51.79
0.1
0.19%
Pre-Market: 6:29 AM EDT
15 minutes delayed
Get Report
Comment
Q2 2024 Earnings were released on Thu Jul 25th, before the market open
The most recent conference call was at 8:30 AM, 6 days ago
Click to view past webcast
Sanofi (SNY) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Sanofi (NASDAQ:SNY) Stock
Sanofi Stock (NASDAQ: SNY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, July 26, 2024
Argus Research Maintains Buy on Sanofi, Raise...
Benzinga Newsdesk
Thursday, July 25, 2024
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
Piero Cingari
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
Vandana Singh
Sanofi shares are trading higher following a ...
Benzinga Newsdesk
Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House
Shanthi Rexaline
American Airlines, AstraZeneca And 3 Stocks To Watch Heading Into Thursday
Avi Kapoor
Teva And Sanofi Fast-Track Anti-TL1A Phase 2b...
Benzinga Newsdesk
Sanofi Upgrades 2024 Business EPS Guidance, N...
Benzinga Newsdesk
Sanofi Q2 2024 Adj EPS $0.93 Beats $0.86 Esti...
Benzinga Newsdesk
Tuesday, July 23, 2024
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
Benzinga Neuro
Sunday, July 21, 2024
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
Shanthi Rexaline
Wednesday, July 17, 2024
European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment
Vandana Singh
'Sanofi's Consumer Arm Said to Draw Bids From...
Benzinga Newsdesk
Tuesday, July 16, 2024
Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
Vandana Singh
Friday, July 12, 2024
Sanofi's $20B Consumer Health Unit Sale: Goldman Sachs, Morgan Stanley Line Up $6.5B Financing
Vandana Singh
Banks Planning €6B Debt Financing For Sanofi ...
Benzinga Newsdesk
Thursday, July 11, 2024
Bernie Sanders Targets High Prices of Ozempic and Wegovy In US
Vandana Singh
EXCLUSIVE: VeeCon 2024 Announces Danica Patrick, Jerome Bettis, Paul Scheer, Mike Posner, Liquid Death CEO Mike Cessario As New Speakers
Chris Katje
Wednesday, July 10, 2024
Sanofi Ships U.S. Influenza Vaccines For 2024...
Benzinga Newsdesk
Wednesday, July 03, 2024
Sanofi CEO Says Talking To Private Equity For...
Benzinga Newsdesk
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Vandana Singh
Tuesday, July 02, 2024
Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
Vandana Singh
Monday, July 01, 2024
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Vandana Singh
Friday, June 28, 2024
Denali Outperforms Industry in 3 Months: Here's Why
Zacks
Sanofi's Frexalimab Phase 2 Data Shows 41% Re...
Benzinga Newsdesk
Thursday, June 27, 2024
CDC's ACIP Unanimously Votes To Add Merck And...
Benzinga Newsdesk
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
Vandana Singh
Vigil Neuroscience Secures $40M from Sanofi, ...
Benzinga Newsdesk
Wednesday, June 26, 2024
Regeneron, Sanofi Present Phase 3 Trial For D...
Benzinga Newsdesk
Sanofi shares are trading lower amid a possib...
Benzinga Newsdesk
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
Vandana Singh
Tuesday Sanofi Announced Riliprubart One-year...
Benzinga Newsdesk
Tuesday, June 25, 2024
Sanofi Seeks Bids For $20B Consumer Arm By Mi...
Benzinga Newsdesk
Friday, June 21, 2024
Sanofi To Present ALTUVIIIO's Long-Term Effic...
Benzinga Newsdesk
Thursday, June 20, 2024
Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
Vandana Singh
Sanofi and Biovac Announce Partnership to Man...
Benzinga Newsdesk
Tuesday, June 18, 2024
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks
Monday, June 17, 2024
Innate Pharma And Sanofi's Blood Cancer Treat...
Benzinga Newsdesk
Wednesday, June 12, 2024
World Health Organization Chief Says At This ...
Benzinga Newsdesk
Tuesday, June 11, 2024
Regeneron, Sanofi Report FDA Approval Of Kevz...
Benzinga Newsdesk
Tuesday, June 04, 2024
Sanofi Highlights Data From Blood Cancer Drug Sarclisa In New Diagnosed Multiple Myeloma Patients
Vandana Singh
Monday, June 03, 2024
Sanofi's IMROZ Phase 3 Study Shows Sarclisa W...
Benzinga Newsdesk
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward
Vandana Singh
'DHl Supply Chain Expands Pharma Logistics Op...
Benzinga Newsdesk
Friday, May 31, 2024
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Vandana Singh
Sanofi And Regeneron Pharmaceuticals' Dupixen...
Benzinga Newsdesk
FDA Extends Priority Review Deadline For Rege...
Benzinga Newsdesk
Wednesday, May 29, 2024
VeeCon 2024 Speakers Announced: X CEO Linda Yaccarino, Content Creator Khaby Lame, Gary Vee Among Special Guests To Appear At Festival That Combines Business, Pop Culture, Web3
Chris Katje
Tuesday, May 28, 2024
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
Avi Kapoor
Reported Monday, Sanofi's Sarclisa Accepted F...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch